Skip to main content
Top

Current Treatment Options in Oncology

Issue 7/2020

Content (8 Articles)

NSCLC Lung Cancer (HA Wakelee and TA Leal, Section Editors)

Optimal Management of Patients with Advanced NSCLC Harboring High PD-L1 Expression and Driver Mutations

Justin A. Chen, Jonathan W. Riess

Metastasis Gynecologic Cancers (LA Cantrell, Section Editor)

Stereotactic Ablative Radiotherapy for Recurrent or Metastatic Gynecological Cancer: Extending Lives?

Tina W. Zhang, David Palma, David D’Souza, Vikram Velker, Lucas C. Mendez

Breast Cancer Cardio-oncology (MG Fradley, Section Editor)

Exercise Training for Cancer Survivors

Calvin K.W. Tong, Benny Lau, Margot K. Davis

Liposarcoma Sarcoma (SH Okuno, Section Editor)

Defining Which Patients Are at High Risk for Recurrence of Soft Tissue Sarcoma

Gaya Spolverato, Dario Callegaro, Alessandro Gronchi

Tyrosine Kinase Inhibitors Sarcoma (SH Okuno, Section Editor)

Revolutions in treatment options in gastrointestinal stromal tumours (GISTs): the latest updates

Sheima Farag, Myles J. Smith, Nicos Fotiadis, Anastasia Constantinidou, Robin L. Jones

Systemic Therapy Breast Cancer (WJ Gradishar, Section Editor)

Management of the Axilla after Neoadjuvant Systemic Therapy

Trista J. Stankowski-Drengler, Heather B. Neuman

Breast Cancer Breast Cancer (WJ Gradishar, Section Editor)

Clinical Development of PD-1/PD-L1 Inhibitors in Breast Cancer: Still a Long Way to Go

Romualdo Barroso-Sousa, Sara M. Tolaney

Acute Lymphoblastic Leukemia Leukemia (PH Wiernik, Section Editor)

Biology and Treatment Paradigms in T Cell Acute Lymphoblastic Leukemia in Older Adolescents and Adults

Anand A. Patel, Joseph Thomas, Alexandra E. Rojek, Wendy Stock

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine